415 related articles for article (PubMed ID: 31060600)
1. Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco.
Carter J; Zevin B; Lum PJ
Addict Sci Clin Pract; 2019 May; 14(1):20. PubMed ID: 31060600
[TBL] [Abstract][Full Text] [Related]
2. Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder.
Williams AR; Samples H; Crystal S; Olfson M
Am J Psychiatry; 2020 Feb; 177(2):117-124. PubMed ID: 31786933
[TBL] [Abstract][Full Text] [Related]
3. Mobile, Community-Based Buprenorphine Treatment for Veterans Experiencing Homelessness With Opioid Use Disorder: A Pilot, Feasibility Study.
Iheanacho T; Payne K; Tsai J
Am J Addict; 2020 Nov; 29(6):485-491. PubMed ID: 32367557
[TBL] [Abstract][Full Text] [Related]
4. Opioid maintenance treatment as a harm reduction tool for opioid-dependent individuals in New York City: the need to expand access to buprenorphine/naloxone in marginalized populations.
Stancliff S; Joseph H; Fong C; Furst T; Comer SD; Roux P
J Addict Dis; 2012; 31(3):278-87. PubMed ID: 22873189
[TBL] [Abstract][Full Text] [Related]
5. Association of buprenorphine retention and subsequent adverse outcomes following non-fatal overdose: An analysis using statewide linked Maryland databases.
Sugarman OK; Saloner B; Richards TM; Lasser EC; Heath T; Idries S; Weiner JP; Bandara S
Drug Alcohol Depend; 2024 May; 258():111281. PubMed ID: 38599134
[TBL] [Abstract][Full Text] [Related]
6. A retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine/naloxone clinic.
Matson SC; Hobson G; Abdel-Rasoul M; Bonny AE
J Addict Med; 2014; 8(3):176-82. PubMed ID: 24695018
[TBL] [Abstract][Full Text] [Related]
7. Health Care Utilization of Opioid Overdose Decedents with No Opioid Analgesic Prescription History.
Abbasi AB; Salisbury-Afshar E; Jovanov D; Berberet C; Arunkumar P; Aks SE; Layden JE; Pho MT
J Urban Health; 2019 Feb; 96(1):38-48. PubMed ID: 30607879
[TBL] [Abstract][Full Text] [Related]
8. Low Barrier Tele-Buprenorphine in the Time of COVID-19: A Case Report.
Harris M; Johnson S; Mackin S; Saitz R; Walley AY; Taylor JL
J Addict Med; 2020; 14(4):e136-e138. PubMed ID: 32433364
[TBL] [Abstract][Full Text] [Related]
9. Office-Based Addiction Treatment Retention and Mortality Among People Experiencing Homelessness.
Fine DR; Lewis E; Weinstock K; Wright J; Gaeta JM; Baggett TP
JAMA Netw Open; 2021 Mar; 4(3):e210477. PubMed ID: 33662132
[TBL] [Abstract][Full Text] [Related]
10. Integrating buprenorphine treatment into a public healthcare system: the San Francisco Department of Public Health's office-based Buprenorphine Pilot Program.
Hersh D; Little SL; Gleghorn A
J Psychoactive Drugs; 2011; 43(2):136-45. PubMed ID: 21858959
[TBL] [Abstract][Full Text] [Related]
11. COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management.
Mehtani NJ; Ristau JT; Snyder H; Surlyn C; Eveland J; Smith-Bernardin S; Knight KR
Subst Abus; 2021; 42(2):205-212. PubMed ID: 33684331
[TBL] [Abstract][Full Text] [Related]
12. Building bridges to outpatient treatment services for post-overdose care via paramedic buprenorphine field initiation.
Belden C; Kopak A; Coules C; Friesen T; Hall J; Shukla S
J Subst Use Addict Treat; 2024 Jul; 162():209364. PubMed ID: 38626851
[TBL] [Abstract][Full Text] [Related]
13. Characterizing acute and postsurgical pain management in patients receiving buprenorphine or buprenorphine/naloxone.
Jones AC; Tillman F; Kahlon C; Seys R; Pepin M
J Am Pharm Assoc (2003); 2024; 64(3):102035. PubMed ID: 38364887
[TBL] [Abstract][Full Text] [Related]
14. Impact of Emergency Department-Initiated Buprenorphine on Repeat Emergency Department Utilization.
Skains RM; Reynolds L; Carlisle N; Heath S; Covington W; Hornbuckle K; Walter L
West J Emerg Med; 2023 Nov; 24(6):1010-1017. PubMed ID: 38165181
[TBL] [Abstract][Full Text] [Related]
15. The cascade of care for opioid use disorder: a retrospective study in British Columbia, Canada.
Piske M; Zhou H; Min JE; Hongdilokkul N; Pearce LA; Homayra F; Socias ME; McGowan G; Nosyk B
Addiction; 2020 Aug; 115(8):1482-1493. PubMed ID: 31899565
[TBL] [Abstract][Full Text] [Related]
16. Association between Participation in Counseling and Retention in a Buprenorphine-Assisted Treatment Program for People Experiencing Homelessness with Opioid Use Disorder.
Berry ARW; Finlayson TL; Mellis LM; Urada LA
Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769591
[TBL] [Abstract][Full Text] [Related]
17. Opioid use disorder treatment for people experiencing homelessness: A scoping review.
McLaughlin MF; Li R; Carrero ND; Bain PA; Chatterjee A
Drug Alcohol Depend; 2021 Jul; 224():108717. PubMed ID: 33985863
[TBL] [Abstract][Full Text] [Related]
18. Predictors of seeking emergency medical help during overdose events in a provincial naloxone distribution programme: a retrospective analysis.
Ambrose G; Amlani A; Buxton JA
BMJ Open; 2016 Jun; 6(6):e011224. PubMed ID: 27329442
[TBL] [Abstract][Full Text] [Related]
19. Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder.
Greenwald MK; Wiest KL; Haight BR; Laffont CM; Zhao Y
Harm Reduct J; 2023 Dec; 20(1):173. PubMed ID: 38042801
[TBL] [Abstract][Full Text] [Related]
20. Association of Opioid Use Disorder Treatment With Alcohol-Related Acute Events.
Xu KY; Presnall N; Mintz CM; Borodovsky JT; Bhat NR; Bierut LJ; Grucza RA
JAMA Netw Open; 2021 Feb; 4(2):e210061. PubMed ID: 33625511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
